,outcome,arm 1,arm 2
0,intervention,D-99 patients,
0,Protocol-defined cardiotoxicity was,"13 % of TLC, 2 cases",D-99 patients
0,"Protocol-defined cardiotoxicity was, total study group","29 % of doxorubicin, 9 cases, CHF )","29 % of doxorubicin, 9 cases, CHF )"
